Why we won't inject exosomes
A treatment we are asked for, and decline. The reasoning behind a line we won't cross.
Every so often a client arrives having read that injected exosomes are the next thing, and asks us to perform the treatment. We say no, and we explain why.
The evidence is not there yet
The claims attached to injectable exosomes outpace the published evidence by a wide margin. We are willing to wait for good data rather than treat our clients as the data.
The regulation is not there yet
Injectable, particularly human-derived, exosome products sit in a contested regulatory space. We will not deliver a treatment whose regulatory footing we cannot stand behind without hesitation.
Restraint is the point
Saying no to a treatment a client is willing to pay for is not a commercial instinct. It is the whole basis of how we practise. The clients we keep are the ones who understand that a clinic's refusals tell you as much as its menu.
More from the Journal